SRI-011381抑制劑SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
| 產品名稱： | SRI-011381 | ||
| 英文名： | SRI-011381 | ||
| CAS NO.： | 1629138-41-5 | ||
| 分子式： | |||
| 分子量： | |||
| 產品品牌： | targetmol | ||
| 產品規格： | 2mg | ||
